Spots Global Cancer Trial Database for Minimally Invasive Surgery in Treating Patients With Spinal Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Minimally Invasive Surgery in Treating Patients With Spinal Tumors

Official Title: Comparison of Minimally Invasive Approaches of Spine Tumor Surgery

Study ID: NCT01308489

Conditions

Adult Spinal Cord Neoplasm

Recurrent Adult Spinal Cord Neoplasm

Spinal Bone Metastases

Spinal Cord Metastases

Interventions

therapeutic conventional surgery

quality-of-life assessment

Study Description

Brief Summary: This randomized clinical trial studies minimally invasive surgery in treating patients with spinal tumors. Posterior spinal tumor resection and anterior and posterior spinal tumor resection are less invasive types of surgery for spinal tumors and may have fewer side effects and improve recovery

Detailed Description: PRIMARY OBJECTIVES: I. Length of operation (operating room \[OR\] time). II. Estimated blood loss (EBL). III. Complication rate. IV. Neurological preservation. SECONDARY OBJECTIVES: I. Motor strength and sensory level (neurological outcome). II. Bladder and bowel function. III. Post-operative pain. IV. Hospital length of stay (recovery time). V. Arthrodesis. OUTLINE: Patients are randomized to 1 of 2 treatment arms. ARM I: Patients undergo posterior spinal tumor resection on day 0. ARM II: Patients undergo anterior and posterior spinal tumor resection on day 0. After completion of study treatment, patients are followed up for 6 months.